MiRus has earned New Technology Add-On Payment from CMS for its EUROPA Posterior Cervical System.
The system is used for the treatment of the cervical and upper thoracic spine and is built around the company’s 2.9 mm MoRe rod, according to an Aug. 1 news release from MiRus.
The EUROPA PCF System has also been awarded Breakthrough Device Designation by the FDA.
By utilizing lower diameter rods, surgeons can perform more durable and less invasive spine procedures, the release said.
